The Sauber F1 Team is pleased to announce Gabrielle's Angel Foundation for Cancer Research as its charity partner.
Gabrielle’s Angel Foundation funds junior scientific investigators conducting research in the fields of leukaemia, lymphoma and related cancers. Since its inception, Gabrielle’s Angel Foundation has awarded grants totalling $25 million and maintains its status as one of the largest non-governmental sources of grant support for blood cancer research in the United States. In 2011, the Foundation announced the creation of its sister chapter, Gabrielle’s Angel Foundation UK, which expands its mission to fund similar research in the United Kingdom.
The Sauber F1 Team and Gabrielle’s Angel Foundation are planning joint merchandise, fan and media campaigns. In addition, the foundation’s logo will be visible on the inside of the rear wing endplates of the Sauber C33-Ferrari.
Monisha Kaltenborn, Team Principal: “The work of Gabrielle’s Angel Foundation contributes significantly to cancer research. The World Health Organisation recently published its world cancer report, which reveals that cancer is growing at an alarming pace. Healing and prevention strategies are vital and research into those is essential. We are proud to be able to provide the Foundation with a platform in order to reach a world wide audience. We are happy to help raise the profile of this fundamentally important research through the sport of Formula One, and we are very much looking forward to a successful partnership.”
Denise Rich, Founder Gabrielle’s Angel Foundation, added: “We are honoured to have the support and strength of the Sauber F1 Team behind us in the fight against cancer. Through Gabrielle’s Angel Foundation’s partnership with the Sauber F1 Team, we will bring a greater universal awareness to the cause and jointly enhance the activities for raising funds needed to support scientists developing new and innovative cancer treatments.”
Gabrielle’s Angel Foundation for Cancer Research was created in 1996, when Grammy-nominated songwriter and philanthropist Denise Rich lost her daughter Gabrielle, a vibrant 27-year-old actress and Hodgkin’s lymphoma survivor, to acute myelogenous leukaemia. Gabrielle’s mother and sisters, Daniella Rich Kilstock and Ilona Rich Schachter, believed the best way to honour Gabrielle’s memory was to create a Foundation that would fund the best and brightest scientific researchers with the hope that less toxic treatments, and ultimately a cure, might be discovered.
